Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)

• Main Authors: M. M. Loukianov (Author), S. Yu. Martsevich (Author), E. Yu. Andrenko (Author), S. S. Yakushin (Author), A. N. Vorobiev (Author), K. G. Pereverzeva (Author), A. V. Zagrebelny (Author), Е. Yu. Okshina (Author), V. V. Yakusevich (Author), Vl. Vl. Yakusevich (Author), E. M. Pozdnyakova (Author), T. A. Gomova (Author), E. E. Fedotova (Author), M. M. Valiakhmetov (Author), V. P. Mikhin (Author), Yu. V. Maslennikova (Author), E. N. Belova (Author), V. G. Klyashtorny (Author), E. V. Kudryashov (Author), A. N. Makoveeva (Author), Ju. E. Tatsii (Author), S. A. Boytsov (Author), O. M. Drapkina (Author)
• Format: Book
• Published: Столичная издательская компания, 2021-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials and methods. 3169 patients with AF were enrolled...